BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26947234)

  • 1. Activation of transient receptor potential vanilloid 1 accelerates re-endothelialization and inhibits neointimal formation after vascular injury.
    Su L; Zhang Y; He K; Wei S; Pei H; Wang Q; Yang D; Yang Y
    J Vasc Surg; 2017 Jan; 65(1):197-205.e2. PubMed ID: 26947234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
    Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.
    Guo J; Breen DM; Pereira TJ; Dalvi PS; Zhang H; Mori Y; Ghanim H; Tumiati L; Fantus IG; Bendeck MP; Dandona P; Rao V; Dolinsky VW; Heximer SP; Giacca A
    Atherosclerosis; 2015 Jul; 241(1):111-20. PubMed ID: 25974101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1.
    Ching LC; Kou YR; Shyue SK; Su KH; Wei J; Cheng LC; Yu YB; Pan CC; Lee TS
    Cardiovasc Res; 2011 Aug; 91(3):492-501. PubMed ID: 21493704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mitochondrial transient receptor potential vanilloid 1 channel contributes to microglial migration.
    Miyake T; Shirakawa H; Nakagawa T; Kaneko S
    Glia; 2015 Oct; 63(10):1870-82. PubMed ID: 26010461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase.
    Guo BC; Wei J; Su KH; Chiang AN; Zhao JF; Chen HY; Shyue SK; Lee TS
    Mol Nutr Food Res; 2015 Apr; 59(4):646-57. PubMed ID: 25581901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-induced protein 35 inhibits endothelial cell proliferation, migration and re-endothelialization of injured arteries by inhibiting the nuclear factor-kappa B pathway.
    Jian D; Wang W; Zhou X; Jia Z; Wang J; Yang M; Zhao W; Jiang Z; Hu X; Zhu J
    Acta Physiol (Oxf); 2018 Jul; 223(3):e13037. PubMed ID: 29350881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
    Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury.
    Sonnenschein K; Fiedler J; Pfanne A; Just A; Mitzka S; Geffers R; Pich A; Bauersachs J; Thum T
    Cardiovasc Res; 2019 Oct; 115(12):1804-1810. PubMed ID: 30843048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction.
    Sun J; Pu Y; Wang P; Chen S; Zhao Y; Liu C; Shang Q; Zhu Z; Liu D
    Cardiovasc Diabetol; 2013 Apr; 12():69. PubMed ID: 23607427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
    Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
    Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α7 Nicotinic acetylcholine receptor contributes to the alleviation of lung ischemia-reperfusion injury by transient receptor potential vanilloid type 1 stimulation.
    Li X; Xu Y; Cheng Y; Wang R
    J Surg Res; 2018 Oct; 230():164-174. PubMed ID: 30100034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of neointimal formation with netrin-1 and netrin-1 preconditioned endothelial progenitor cells.
    Liu NM; Siu KL; Youn JY; Cai H
    J Mol Med (Berl); 2017 Mar; 95(3):335-348. PubMed ID: 28004124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1.
    Kessler T; Zhang L; Liu Z; Yin X; Huang Y; Wang Y; Fu Y; Mayr M; Ge Q; Xu Q; Zhu Y; Wang X; Schmidt K; de Wit C; Erdmann J; Schunkert H; Aherrahrou Z; Kong W
    Circulation; 2015 Mar; 131(13):1191-201. PubMed ID: 25712208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia.
    Stiber JA; Wu JH; Zhang L; Nepliouev I; Zhang ZS; Bryson VG; Brian L; Bentley RC; Gordon-Weeks PR; Rosenberg PB; Freedman NJ
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):984-93. PubMed ID: 27013612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury.
    Yoshida T; Yamashita M; Horimai C; Hayashi M
    J Am Heart Assoc; 2014 Jan; 3(1):e000622. PubMed ID: 24470523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coptisine inhibits neointimal hyperplasia through attenuating Pak1/Pak2 signaling in vascular smooth muscle cells without retardation of re-endothelialization.
    Chen Y; Jiang X; Yuan Y; Chen Y; Wei S; Yu Y; Zhou Q; Yu Y; Wang J; Liu H; Hua X; Yang Z; Chen Z; Li Y; Wang Q; Chen J; Wang Y
    Atherosclerosis; 2024 Apr; 391():117480. PubMed ID: 38447436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury.
    Tsihlis ND; Murar J; Kapadia MR; Ahanchi SS; Oustwani CS; Saavedra JE; Keefer LK; Kibbe MR
    J Vasc Surg; 2010 May; 51(5):1248-59. PubMed ID: 20223627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative effects of TRPV1 ligands on nonspecific and enteroantigen-specific T cells from wild-type and Trpv1 KO mice.
    Belmaáti MS; Diemer S; Hvarness T; Baumann K; Pedersen AE; Christensen RE; Claesson MH
    Inflamm Bowel Dis; 2014 Jun; 20(6):1004-14. PubMed ID: 24788222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol suppression of arterial intimal hyperplasia is associated with decreased expression of sialyl Lewis X homing receptors on mononuclear cells and E-selectin in endothelial cells.
    Takigawa T; Tsurushima H; Suzuki K; Tsuruta W; Nakamura K; Matsumura A
    J Vasc Surg; 2012 Feb; 55(2):506-16. PubMed ID: 22264805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.